Therapies
Thursday, August 7th, 2014
STROKEAHA: July 1, 2014 Hypertension is the premier modifiable risk factor for stroke.1,2 Indeed, ≤50% of strokes may be attributable to hypertension, and the relationship of hypertension with stroke also comprises distinct independent links between both systolic and diastolic hypertension and the occurrence of both primary and recurrent strokes.3 Furthermore, the underlying pathophysiological rationale and clinical trial evidence […]
Therapies
Thursday, August 7th, 2014
STROKEAHA: June 19, 2014 After rehabilitation, most stroke survivors return to the community and continue with their daily lives, despite stroke-related functional, cognitive, and behavioral changes.1Caregivers are the primary support system for these survivors after discharge and an integral part of the healthcare team that contributes to survivors’ rehabilitation and recovery.2,3 However, caregiving is stressful, and caregivers […]
Guidelines
Thursday, August 7th, 2014
STROKEAHA: 8/1/14 Literature on the anesthetic management of endovascular treatment of acute ischemic stroke (AIS) is limited. Anesthetic management during these procedures is still mostly dependent on individual or institutional preferences. Thus, the Society of Neuroscience in Anesthesiology and Critical Care (SNACC) created a task force to provide expert consensus recommendations on anesthetic management of endovascular […]
News
Thursday, August 7th, 2014
STROKEAHA: July 29, 2014 Background and Purpose—Mexican Americans (MAs) were previously found to have lower mortality after ischemic stroke than non-Hispanic whites. We studied mortality trends in a population-based design. Methods—Active and passive surveillance were used to find all ischemic stroke cases from January 2000 to December 2011 in Nueces County, TX. Deaths were ascertained […]
News
Thursday, August 7th, 2014
STROKEAHA: July 24, 2014 Background and Purpose—Mortality after first-ever stroke, and particularly after recurrent stroke, and predictors of long-term mortality among young and middle-aged stroke patients are not well-known. We assessed 17-year risk of mortality with focus on the effect of recurrence on the risk of death of young and middle-aged patients with stroke. Methods—Mortality and […]
News
Thursday, August 7th, 2014
IJTR: 03 Jul 2014 Background: The aim of this study was to identify functional, emotional and cognitive problems following transient ischaemic attack (TIA) and minor stroke (mS). Methods: Participants were recruited from patients who were attending a TIA and minor stroke clinic. A control group of healthy adults was recruited through community groups. Participants were asked […]
News
Thursday, August 7th, 2014
STROKEAHA: July 1, 2014 The Patient Protection and Affordable Care Act (ACA) was enacted on March 23, 2010, and has important implications for stroke care. The ACA is a comprehensive reform, although the signature component is the expansion of health insurance primarily by expanding Medicaid eligibility and by providing subsidies for consumers to purchase private insurance […]
News
Thursday, August 7th, 2014
STROKEAHA: June 26, 2014 Background and Purpose—We investigated whether the brachial-ankle pulse wave velocity (baPWV) has prognostic value for predicting functional outcome after acute cerebral infarction and whether the prognostic value differs between stroke subtypes. Methods—We included 1091 consecutive patients with first-ever acute cerebral infarction who underwent baPWV measurements. Stroke subtypes were classified using the Trial […]
Atrial Fibrillation
Thursday, August 7th, 2014
BMC Health Services Research 2014 Background Dabigatran is one of the three newer oral anticoagulants (OACs) recently approved in the United States for stroke prevention in non-valvular atrial fibrillation (NVAF) patients. The objective of this study was to identify patient, healthcare provider, and health plan factors associated with dabigatran versus warfarin use among NVAF patients. Methods […]
